JP2010538618A5 - - Google Patents

Download PDF

Info

Publication number
JP2010538618A5
JP2010538618A5 JP2010524259A JP2010524259A JP2010538618A5 JP 2010538618 A5 JP2010538618 A5 JP 2010538618A5 JP 2010524259 A JP2010524259 A JP 2010524259A JP 2010524259 A JP2010524259 A JP 2010524259A JP 2010538618 A5 JP2010538618 A5 JP 2010538618A5
Authority
JP
Japan
Prior art keywords
donor
antibody
library
specific antibody
vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010524259A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010538618A (ja
Filing date
Publication date
Priority claimed from US11/853,795 external-priority patent/US8148085B2/en
Application filed filed Critical
Publication of JP2010538618A publication Critical patent/JP2010538618A/ja
Publication of JP2010538618A5 publication Critical patent/JP2010538618A5/ja
Withdrawn legal-status Critical Current

Links

JP2010524259A 2007-09-11 2008-09-11 ドナー特異的抗体ライブラリー Withdrawn JP2010538618A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/853,795 US8148085B2 (en) 2006-05-15 2007-09-11 Donor specific antibody libraries
PCT/US2008/075998 WO2009036157A1 (en) 2007-09-11 2008-09-11 Donor specific antibody libraries

Publications (2)

Publication Number Publication Date
JP2010538618A JP2010538618A (ja) 2010-12-16
JP2010538618A5 true JP2010538618A5 (enExample) 2012-11-15

Family

ID=40220152

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010524259A Withdrawn JP2010538618A (ja) 2007-09-11 2008-09-11 ドナー特異的抗体ライブラリー

Country Status (6)

Country Link
US (3) US8148085B2 (enExample)
EP (1) EP2190477A1 (enExample)
JP (1) JP2010538618A (enExample)
CN (1) CN101854950A (enExample)
AU (1) AU2008298939A1 (enExample)
WO (1) WO2009036157A1 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7584439B2 (en) * 2006-12-07 2009-09-01 Agere Systems Inc. Cell modeling for integrated circuit design with characterization of upstream driver strength
CA2787099A1 (en) 2009-03-30 2010-10-14 Anice C. Lowen Influenza virus hemagglutinin polypeptides containing stem domains, vaccines and uses thereof
WO2010130636A1 (en) * 2009-05-11 2010-11-18 Crucell Holland B.V. Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof
CN102482345A (zh) * 2009-05-13 2012-05-30 航道生物技术有限责任公司 针对流感病毒的中和分子
AU2010254136B2 (en) * 2009-05-26 2016-09-29 Mount Sinai School Of Medicine Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof
US20110077966A1 (en) * 2009-09-28 2011-03-31 Augusta E.N.T., P.C. Allergy electronic medical record system and method
US9701723B2 (en) 2010-02-18 2017-07-11 Icahn School Of Medicine At Mount Sinai Vaccines for use in the prophylaxis and treatment of influenza virus disease
CN102939103A (zh) 2010-03-30 2013-02-20 西奈山医学院 流感病毒疫苗及其应用
US20120107355A1 (en) * 2010-10-27 2012-05-03 Harrisvaccines, Inc. Method of rapidly producing improved vaccines for animals
US20230287392A1 (en) * 2011-04-28 2023-09-14 The Board Of Trustees Of The Leland Stanford Junior University Identification of Polynucleotides Associated with a Sample
EP3421592B1 (en) * 2011-04-28 2023-09-13 The Board of Trustees of the Leland Stanford Junior University Identification of polynucleotides associated with a sample
KR20140068205A (ko) 2011-09-20 2014-06-05 마운트 시나이 스쿨 오브 메디슨 인플루엔자 바이러스 백신 및 이의 용도
CA2850720C (en) 2011-09-30 2016-03-29 Celltrion Inc. Binding molecule having influenza a virus-neutralizing activity produced from human b cell
US9977861B2 (en) 2012-07-18 2018-05-22 Illumina Cambridge Limited Methods and systems for determining haplotypes and phasing of haplotypes
UA118441C2 (uk) 2012-10-08 2019-01-25 Протена Біосаєнсиз Лімітед Антитіло, що розпізнає альфа-синуклеїн
KR20150104117A (ko) 2012-12-18 2015-09-14 이칸 스쿨 오브 메디슨 엣 마운트 시나이 인플루엔자 바이러스 백신 및 그의 용도
WO2014159960A1 (en) 2013-03-14 2014-10-02 Icahn School Of Medicine At Mount Sinai Antibodies against influenza virus hemagglutinin and uses thereof
AR096601A1 (es) 2013-06-21 2016-01-20 Novartis Ag Anticuerpos del receptor 1 de ldl oxidado similar a lectina y métodos de uso
US9562101B2 (en) * 2013-06-21 2017-02-07 Novartis Ag Lectin-like oxidized LDL receptor 1 antibodies and methods of use
WO2015004632A1 (en) 2013-07-12 2015-01-15 Neotope Biosciences Limited Antibodies that recognize iapp
WO2015004633A1 (en) 2013-07-12 2015-01-15 Neotope Biosciences Limited Antibodies that recognize islet-amyloid polypeptide (iapp)
US20150225770A1 (en) * 2014-02-12 2015-08-13 U.S. Army Research Laboratory Attn: Rdrl-Loc-I Phenotype-neutral barcodes for digital analysis
KR101740030B1 (ko) 2014-03-07 2017-05-29 사회복지법인 삼성생명공익재단 ScFv 항체 라이브러리, 이의 제조방법 및 이를 이용한 ScFv 항체 스크리닝 방법
DK3126384T3 (da) * 2014-04-01 2021-01-18 Adimab Llc Multispecifikke antistofanaloger omfattende en fælles letkæde, og fremgangsmåder til deres fremstilling og anvendelse
CA2944402A1 (en) 2014-04-08 2015-10-15 Prothena Biosciences Limited Blood-brain barrier shuttles containing antibodies recognizing alpha-synuclein
US20180008702A1 (en) * 2014-12-05 2018-01-11 Celltrion Inc. Adjuvant composition containing at least one influenza virus neutralizing and binding molecule and vaccine composition containing same
US10736956B2 (en) 2015-01-23 2020-08-11 Icahn School Of Medicine At Mount Sinai Influenza virus vaccination regimens
CN107614762B (zh) * 2015-02-24 2022-08-05 台湾地区“中央研究院” 一种由噬菌体表达的单链变异片段抗体库
AU2016315941B2 (en) * 2015-09-01 2022-09-08 The Regents Of The University Of California Modular polypeptide libraries and methods of making and using same
WO2017218624A1 (en) 2016-06-15 2017-12-21 Icahn School Of Medicine At Mount Sinai Influenza virus hemagglutinin proteins and uses thereof
KR102264642B1 (ko) * 2016-10-31 2021-06-15 유니베르시태트 취리히 단백질 스크리닝 및 검출 방법
WO2018187706A2 (en) 2017-04-07 2018-10-11 Icahn School Of Medicine At Mount Sinai Anti-influenza b virus neuraminidase antibodies and uses thereof
EP3810634A4 (en) 2018-06-21 2022-07-27 Icahn School of Medicine at Mount Sinai Mosaic influenza virus hemagglutinin polypeptides and uses thereof
EP3959216A4 (en) 2019-04-24 2023-01-11 Icahn School of Medicine at Mount Sinai ANTI-INFLUENZA B VIRUS NEURAMINIDASE ANTIBODIES AND USES THEREOF
US20220283161A1 (en) * 2019-07-25 2022-09-08 The Johns Hopkins University Methods and compositions for hepatitis c virus (hcv)
WO2025019631A1 (en) 2023-07-19 2025-01-23 Icahn School Of Medicine At Mount Sinai Immunogenic compositions containing inactivated influenza a virus and cpg oligonucleotide adjuvant and uses thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA836080B (en) 1982-08-23 1984-04-25 Scripps Clinic Res Broad spectrum influenza antisera
US5667988A (en) 1992-01-27 1997-09-16 The Scripps Research Institute Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
US6337070B1 (en) 1993-04-29 2002-01-08 Takara Shuzo Co., Ltd. Polypeptides for use in generating anti-human influenza virus antibodies
EP0699750A1 (en) * 1994-06-07 1996-03-06 Gesellschaft für biotechnologische Forschung mbH (GBF) A collection of phagemids, a collection of Escherichia coli cells carrying the phagemids, a collection of phagemid particles produced from said collection and phagemid particles obtained according to the process
US6169175B1 (en) * 1997-08-06 2001-01-02 Centers For Disease Control And Prevention Preparation and use of recombinant influenza A virus M2 construct vaccines
US6607878B2 (en) * 1997-10-06 2003-08-19 Stratagene Collections of uniquely tagged molecules
MXPA01009567A (es) 1999-03-23 2003-08-19 Biovation Ltd Aislamiento y analisis de proteina.
FR2817869B1 (fr) 2000-12-07 2005-01-14 Technopharm Anticorps monoclonal humain dirige contre le virus influenza ou un fragment de celui-ci
DK1360288T3 (da) 2000-12-18 2011-06-14 Dyax Corp Fokuserede biblioteker af genetiske pakker
WO2003052101A1 (en) 2001-12-14 2003-06-26 Rosetta Inpharmatics, Inc. Sample tracking using molecular barcodes
KR20040111402A (ko) 2002-03-13 2004-12-31 기린 비루 가부시키가이샤 인플루엔자 м2 단백질에 대한 인간 모노클로날 항체 및그의 제조 및 사용 방법
US7824856B2 (en) 2003-09-10 2010-11-02 Althea Technologies, Inc. Expression profiling using microarrays
US20060073506A1 (en) 2004-09-17 2006-04-06 Affymetrix, Inc. Methods for identifying biological samples
AU2006290736B2 (en) 2005-09-15 2011-09-15 Crucell Holland B.V. Method for preparing immunoglobulin libraries
GB0522460D0 (en) 2005-11-03 2005-12-14 Prendergast Patrick T Composition and method for the treatment of avian influenza
CA2637837A1 (en) 2006-01-26 2007-08-09 Hx Diagnostics, Inc. Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof
WO2007134327A2 (en) 2006-05-15 2007-11-22 Sea Lane Biotechnologies, Llc. Neutralizing antibodies to influenza viruses
CA2663388C (en) 2006-09-07 2017-01-17 Crucell Holland B.V. Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof
EP2132312B1 (en) 2007-03-27 2016-01-27 Sea Lane Biotechnologies,llc. Constructs and libraries comprising antibody surrogate light chain sequences

Similar Documents

Publication Publication Date Title
JP2010538618A5 (enExample)
JP7828725B2 (ja) がんのネオエピトープ
ES2236605T3 (es) Tecnologia de anticuerpos dirigida.
Neu et al. Spec-seq unveils transcriptional subpopulations of antibody-secreting cells following influenza vaccination
JP2005185286A (ja) 糸球体腎炎および他の炎症性疾患の治療のための組成物および方法
Vishwanath et al. A computationally designed antigen eliciting broad humoral responses against SARS-CoV-2 and related sarbecoviruses
CA2898197C (en) Protein combination-based fv library, and preparation method therefor
JP2009544284A5 (enExample)
JP2024167352A (ja) mRNAディスプレイ抗体ライブラリー及び方法
CN115485392A (zh) 用于鉴别配体阻断性抗体及用于确定抗体效价的方法
Stutz et al. Coupling brain perfusion screens and next generation sequencing to identify blood–brain barrier binding antibodies
Zheng et al. Vaccine molecule design based on phage display and computational modeling against rhabdovirus
Ren et al. RAMIHM generates fully human monoclonal antibodies by rapid mRNA immunization of humanized mice and BCR-seq
Shahsavarian et al. Exploitation of rolling circle amplification for the construction of large phage-display antibody libraries
JP6665274B2 (ja) 標的分子に結合するポリペプチドの決定方法及び決定システム
Sun et al. Generation of a mouse scFv library specific for porcine aminopeptidase N using the T7 phage display system
CN113667011B (zh) 制备抗原结合单元的方法
He et al. Production of human single-chain antibodies by ribosome display
CN106957905A (zh) 一种用于评估肿瘤免疫治疗效果的分子检测方法及引物组合物及试剂盒
CN113710801A (zh) 一种使用cDNA展示的新型免疫PCR方法
Xu et al. Screening of random peptide library of hemagglutinin from pandemic 2009 A (H1N1) influenza virus reveals unexpected antigenically important regions
JP6083728B2 (ja) タンパク質機能改変法
JP2016098198A (ja) Dnaライブラリの製造方法、dnaライブラリ、スクリーニング方法及びスクリーニングキット
Kumari et al. Phage display and human disease detection
Leclerc et al. Evidence of Fab Fragment gene in an Invertebrate: the sea star Asterias rubens